" /> Anti-HER2 Immune Stimulator-antibody Conjugate NJH395 - CISMeF





Preferred Label : Anti-HER2 Immune Stimulator-antibody Conjugate NJH395;

NCIt synonyms : Anti-HER2 ISAC NJH395;

NCIt related terms : NJH-395;

NCIt definition : An immune stimulator-antibody conjugate (ISAC) composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (EGFR2; HER2; ErbB2) conjugated to a not yet disclosed immune stimulator, with potential antineoplastic and immunostimulating activities. Upon administration of the anti-HER2 immune stimulator-antibody conjugate NJH395, the antibody moiety targets and binds to HER2 expressed on tumor cells. Upon antibody/antigen binding, the immune-stimulating moiety may, through an as of yet undisclosed mechanism, enhance the immune-mediated killing of HER2-expressing tumor cells. HER2, a tyrosine kinase receptor, is overexpressed in many cancer types and plays a key role in tumor cell proliferation and tumor vascularization.;

UNII : 301EY96MDU;

Molecule name : NJH-395; NJH 395;

NCI Metathesaurus CUI : CL969413;

Details


You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.